Besides, we show that RECK down regulation is an early trait in cervical cancer history and that RECK levels correlates with protease inhibitors expression, cervical lesions progression, presence of metastases and treatment response in clinical samples. The gene discussed is RECK; the disease is cervical carcinoma.